PIERIS PHARMACEUTICALS, INC. (PIRS) Deferred Tax Assets, Valuation Allowance USD 2013 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pieris Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2013 to 2023.
  • Pieris Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $72.5 M, a 19.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $72.5 M +$11.9 M +19.7% Dec 31, 2023 10-K 2024-03-29
Q4 2022 $60.6 M +$7.35 M +13.8% Dec 31, 2022 10-K 2024-03-29
Q4 2021 $53.2 M +$9.47 M +21.7% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $43.7 M +$9.77 M +28.8% Dec 31, 2020 10-K 2022-03-02
Q4 2019 $34 M +$3.15 M +10.2% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $30.8 M +$5.57 M +22% Dec 31, 2018 10-K 2020-03-13
Q4 2017 $25.3 M +$5.43 M +27.4% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $19.8 M +$5.92 M +42.5% Dec 31, 2016 10-K 2018-03-15
Q4 2015 $13.9 M +$3.99 M +40.2% Dec 31, 2015 10-K 2017-03-30
Q4 2014 $9.92 M -$7.14 M -41.9% Dec 31, 2014 10-K 2016-03-23
Q4 2013 $17.1 M Dec 31, 2013 10-K 2015-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.